TNYA
Tenaya Therapeutics (TNYA)
$77
About Tenaya Therapeutics (TNYA)
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. Its programs include TN-201, TN-401, and TN-301. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Newell Olson in 2016 and is headquartered in South San Francisco, CA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.35
52 Week Low
$0.36
Market cap
132.7M
Dividend yield
0.00%
Volume
--
Avg. volume
6.0M
P/E ratio
-1.01
Tenaya Therapeutics News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.35
52 Week Low
$0.36
Market cap
132.7M
Dividend yield
0.00%
Volume
--
Avg. volume
6.0M
P/E ratio
-1.01